Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.83 +0.04 (+0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Long-Term Investments (2024)

Updated

Artiva Biotherapeutics (ARTV) recorded Long-Term Investments of $52.97 million in Q3 2024.

Analysis

Artiva Biotherapeutics (ARTV) Long-Term Investments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 Artiva Biotherapeutics 267.62 Mn 267.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 52.97 Mn
API Access

Artiva Biotherapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ARTV&period=max&api_key=YOUR_API_KEY